Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tajikistan Health News.
November 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
December 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 |
January 2026
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
Press releases published on November 12, 2025
November 12, 2025
Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting
Indeterminate
GlobeNewswire
November 12, 2025
Anteris Announces Results for the Third Quarter of 2025
Indeterminate
GlobeNewswire
November 12, 2025
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
November 12, 2025
BioCardia Reports Third Quarter 2025 Business Highlights and Financial Results
Indeterminate
GlobeNewswire
November 12, 2025
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
Indeterminate
GlobeNewswire
November 12, 2025
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th
Indeterminate
GlobeNewswire
November 12, 2025
Inventiva announces launch of public offering
Indeterminate
GlobeNewswire
November 12, 2025
Inventiva annonce le lancement d'une offre au public
Indeterminate
GlobeNewswire
November 12, 2025
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
November 12, 2025
LogicMark, Inc. Announces Third Quarter 2025 Results
Indeterminate
GlobeNewswire
November 12, 2025
MaxCyte Announces Planned CFO Transition in 2026
Indeterminate
GlobeNewswire
November 12, 2025
Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Indeterminate
GlobeNewswire
November 12, 2025
Cue Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Indeterminate
GlobeNewswire
November 12, 2025
SELLAS Life Sciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Indeterminate
GlobeNewswire
November 12, 2025
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2025
Indeterminate
GlobeNewswire
November 12, 2025
Immuneering Reports Third Quarter 2025 Financial Results and Provides Business and Clinical Updates
Indeterminate
GlobeNewswire